Form D — Kamau Therapeutics, Inc.
0002071165-25-000001 · filed Jun 3, 2025
Offering
- Industry
- Other Technology
- Exemptions
- 06b
- Total offering
- $10,000,000
- Total sold
- $4,999,997
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Kamau Therapeutics, Inc.
- CIK
- 2071165
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 220 E. GRAND AVENUE
SOUTH SAN FRANCISCO, CA 94080 - Phone
- 628-333-5084
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Valentin Barsan · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
Matthew Porteus · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
Ness Bermingham · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Raymond Kelleher · DirectorSouth San Francisco, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗